Literature DB >> 22730515

Thyroid-stimulating hormone levels within the reference range are associated with serum lipid profiles independent of thyroid hormones.

Furong Wang1, Yinyin Tan, Chenggang Wang, Xu Zhang, Yuanfei Zhao, Xinhong Song, Bingchang Zhang, Qingbo Guan, Jin Xu, Ji Zhang, Dongzhi Zhang, Haiyan Lin, Chunxiao Yu, Jiajun Zhao.   

Abstract

CONTEXT AND
OBJECTIVE: Dyslipidemia in thyroid dysfunction has always been attributed to changes in thyroid hormone (TH) levels. We hypothesized that TSH plays an important role in lipid metabolism independent of TH. DESIGN AND
SETTING: We conducted a cross-sectional study to investigate the relationship between serum TSH levels and lipid profiles after controlling for free T(3), free T(4), total T(3), total T(4) and nonthyroid factors relevant to lipid metabolism in euthyroid Chinese subjects. MAIN OUTCOME MEASURES: General linear analysis was performed to determine whether the impact of TSH on serum lipid levels is independent of the TH levels. Moreover, path analysis, an evolutionary multivariable regression technique, was conducted to test whether there is a direct and/or indirect effect between serum TSH and total cholesterol (TC) levels. Additionally, the odds ratios (95% confidence interval) for hypercholesterolemia in relation to TSH categories were calculated.
RESULTS: A total of 3664 euthyroid subjects were finally analyzed. There was a significant linear trend toward higher log TC (P = 0.021) and log triglyceride (P = 0.001) levels with increasing serum TSH levels within the reference range, which remained significant after adjusting for factors such as TH levels, age, and smoking. Most importantly, the total effect of TSH on TC levels (total effect(TC, TSH) = 0.05253) includes a direct effect (direct effect(TC, TSH) = 0.05979) and an indirect effect via TH. Compared with subjects in the lower part of the reference range (TSH level, 0.27-0.61 mIU/liter), the adjusted odds ratio for hypercholesterolemia was 3.239 (95% confidence interval, 1.392-7.538; P = 0.007) for those in the upper category (TSH level, 4.61-5.5 mIU/liter).
CONCLUSIONS: The variation in normal TSH levels is partially related to the lipid components and hypercholesterolemia in euthyroid subjects and includes both TH-dependent and TH-independent effects. Our study suggests the importance of controlling TSH in hypothyroid subjects.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22730515     DOI: 10.1210/jc.2012-1133

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  37 in total

1.  Genome-wide meta-analysis identifies novel loci associated with free triiodothyronine and thyroid-stimulating hormone.

Authors:  M Popović; A Matana; V Torlak; T Boutin; D Brdar; I Gunjača; D Kaličanin; I Kolčić; V Boraska Perica; A Punda; O Polašek; M Barbalić; C Hayward; T Zemunik
Journal:  J Endocrinol Invest       Date:  2019-03-07       Impact factor: 4.256

Review 2.  Central hypothyroidism and its role for cardiovascular risk factors in hypopituitary patients.

Authors:  Ulla Feldt-Rasmussen; Marianne Klose
Journal:  Endocrine       Date:  2016-08-01       Impact factor: 3.633

3.  Association between blood lead levels and metabolic syndrome considering the effect of the thyroid-stimulating hormone based on the 2013 Korea National health and nutrition examination survey.

Authors:  Ji Yoon Choi; Da-An Huh; Kyong Whan Moon
Journal:  PLoS One       Date:  2020-12-31       Impact factor: 3.240

4.  TSHB mRNA is linked to cholesterol metabolism in adipose tissue.

Authors:  José María Moreno-Navarrete; María Moreno; Francisco Ortega; Gemma Xifra; Shangyu Hong; John M Asara; José C E Serrano; Mariona Jové; Pavlos Pissios; Matthias Blüher; Wifredo Ricart; Manuel Portero-Otin; José Manuel Fernández-Real
Journal:  FASEB J       Date:  2017-06-23       Impact factor: 5.191

5.  Adiposity blunts the positive relationship of thyrotropin with proprotein convertase subtilisin-kexin type 9 levels in euthyroid subjects.

Authors:  Arjan J Kwakernaak; Gilles Lambert; Anneke C Muller Kobold; Robin P F Dullaart
Journal:  Thyroid       Date:  2013-02       Impact factor: 6.568

6.  Functional thyrotropin receptor expression in the ventricle and the effects on ventricular BNP secretion.

Authors:  Wen Huang; Jin Xu; Fei Jing; Wen-Bin Chen; Ling Gao; Hai-Tao Yuan; Jia-Jun Zhao
Journal:  Endocrine       Date:  2013-09-26       Impact factor: 3.633

7.  Triiodothyronine and free thyroxine levels are differentially associated with metabolic profile and adiposity-related cardiovascular risk markers in euthyroid middle-aged subjects.

Authors:  Greet L Roef; Ernst R Rietzschel; Caroline M Van Daele; Youri E Taes; Marc L De Buyzere; Thierry C Gillebert; Jean-Marc Kaufman
Journal:  Thyroid       Date:  2013-11-14       Impact factor: 6.568

8.  Dual-source dual-energy computed tomography-derived quantitative parameters combined with machine learning for the differential diagnosis of benign and malignant thyroid nodules.

Authors:  Liling Jiang; Daihong Liu; Ling Long; Jiao Chen; Xiaosong Lan; Jiuquan Zhang
Journal:  Quant Imaging Med Surg       Date:  2022-02

9.  TSH and Thyrotropic Agonists: Key Actors in Thyroid Homeostasis.

Authors:  Johannes W Dietrich; Gabi Landgrafe; Elisavet H Fotiadou
Journal:  J Thyroid Res       Date:  2012-12-30

10.  Differences and associations of metabolic and vitamin D status among patients with and without sub-clinical hypothyroid dysfunction.

Authors:  Naji J Aljohani; Nasser M Al-Daghri; Omar S Al-Attas; Majed S Alokail; Khalid M Alkhrafy; Abdulaziz Al-Othman; Sobhy Yakout; Abdulaziz F Alkabba; Ahmed S Al-Ghamdi; Mussa Almalki; Badurudeen Mahmood Buhary; Shaun Sabico
Journal:  BMC Endocr Disord       Date:  2013-08-20       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.